Pharmaceutical News

RSS

Benzodiazepine exposure for over-65s linked to increased risk of dementia

The results from comparative analysis of this population demonstrate the risk of developing dementia increased by 50% for subjects who consumed benzodiazepines during the follow-up period, compared with those who had never used benzodiazepines.

6 Oct 2012

Nelfinavir inhibits growth of HER2-positive tumors

The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.

6 Oct 2012

Combination pill to treat malaria pre-approved by WHO

"A malaria drug made by India's Cipla has been pre-qualified by the World Health Organization (WHO), an important step towards its roll-out across Asia, where millions of people are infected with the mosquito-borne disease every year," Reuters reports.

6 Oct 2012

Authorities shut down 18K online pharmacy sites in crackdown of fake drug sales

"Police and regulators around the world have closed 18,000 online pharmacy sites in the past few days, in the largest ever clampdown on criminal gangs selling unauthorized medicines online," the Financial Times reports.

6 Oct 2012

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).

5 Oct 2012

Emergent receives BARDA contract to advance development of novel rPA anthrax vaccine

Emergent BioSolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) has exercised a contract option to further advance the development of PreviThrax (Recombinant Protective Antigen Anthrax Vaccine, Purified), the company's novel rPA anthrax vaccine candidate.

5 Oct 2012

Paper proposes novel mathematical models for injection of insulin in type 1 and 2 diabetes

Diabetes mellitus is a chronic disease in which individuals exhibit high levels of sugar in the blood, either due to insufficient production of insulin-the hormone that allows glucose to be absorbed by body cells-or the body's lack of response to insulin. Type 1 diabetes occurs due to loss or dysfunction of β-cells of the pancreas, the organ that produces insulin. Type 2 diabetes is caused by a defective glucose-insulin regulatory system.

5 Oct 2012

Article explores safety and efficacy of aerosol delivery of drugs in ICU patients

Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.

5 Oct 2012

Overweight children more likely to take prescription medications

Overweight children are far more likely to take prescription medications than children of a normal weight-a trend that adds to already higher health-care costs for treating childhood obesity, according to new research from the University of Alberta.

5 Oct 2012

New ToxIC study identifies current drug poisoning trends

Nonprescription medications are just as likely a cause of poisoning as prescription drugs, according to a new study by Timothy Wiegand, M.D. from the University of Rochester Medical Center in the US and colleagues.

5 Oct 2012

Diabecline wins Drug Store News Best New Product award

Diabecline first aid antibiotic, offered by pharmaCline, has been named the winner of the Drug Store News Best New Product award.

5 Oct 2012

New book on natural interventions for lung cancer

Told he had lung cancer and 6 months to live, the author refused chemo/surgery and used holistic, natural, non-invasive interventions. Now, 38 years later at age 80 he not only beat the odds of lung cancer but also the odds of 3 chronic illnesses and 5 prescribed medications that are the average for a 75 year old.

5 Oct 2012

Sublingual immunotherapy highly effective for chronic allergy and asthma sufferers

Could it be that those with allergic rhinitis (hay fever) and childhood nasal allergies can finally get a break from their allergies and their allergy shots? Chicago's leading allergy, asthma, and immunology expert, Dr. Brian Rotskoff, who treats a large number of Chicago pediatric allergy patients, is happy to say, "Yes!"

5 Oct 2012

Countering neuroinflammation is indeed a potential therapeutic strategy for Alzheimer's

New research proves the validity of one of the most promising approaches for combating Alzheimer's disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease itself, scientists are reporting. The study, in the journal ACS Medicinal Chemistry Letters, also identifies a potential new oral drug that the scientists say could lead the way.

5 Oct 2012

Krembil scientists develop lab study to accurately predict outcomes of stroke neuroprotectant

Scientists at the Krembil Neuroscience Centre, located at the Toronto Western Hospital, University Health Network have developed the first lab study in the world to accurately predict the outcomes of a human clinical for their drug that protects the brain against the damaging effects of stroke.

4 Oct 2012

Ketamine can help improve brain function in Rett syndrome mice

A promising study out today in the prestigious Journal of Neurosciences showed that in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating the animals with an FDA-approved anesthesia drug, ketamine.

4 Oct 2012

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

A new study conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found using beta-blockers, the standard of care for patients with coronary artery disease (CAD), was not associated with a lower risk of heart attacks, death and strokes in patients suffering from CAD and those with risk factors for the disease, including those with a history of heart attack.

4 Oct 2012

Nature examines future of AMFm

"Although no official decision has been announced about whether to continue the ... Affordable Medicines Facility-Malaria (AMFm), many of those familiar with it have told Nature that it must change or be phased out after this year," the magazine reports in an article examining the future of the pilot program that distributes malaria drugs in seven African countries.

4 Oct 2012

Zimbabwe set to attain 'universal' ARV coverage

"Zimbabwe is set to attain 'universal' coverage for AIDS treatment thanks in part to an $84 million disbursement on Tuesday by the United Nations-backed Global Fund to Fight AIDS, Tuberculosis and Malaria," the U.N. News Centre reports.

4 Oct 2012

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

Gender-specific group therapy is effective for treating depressed women with Type 2 diabetes, according to a study published in the latest issue of the Annals of Behavioral Medicine and funded by the National Institute of Nursing Research.

4 Oct 2012

Pharmaceutical News

Benzodiazepine exposure for over-65s linked to increased risk of dementia

Nelfinavir inhibits growth of HER2-positive tumors

Combination pill to treat malaria pre-approved by WHO

Authorities shut down 18K online pharmacy sites in crackdown of fake drug sales

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

Emergent receives BARDA contract to advance development of novel rPA anthrax vaccine

Paper proposes novel mathematical models for injection of insulin in type 1 and 2 diabetes

Article explores safety and efficacy of aerosol delivery of drugs in ICU patients

Overweight children more likely to take prescription medications

New ToxIC study identifies current drug poisoning trends

Diabecline wins Drug Store News Best New Product award

New book on natural interventions for lung cancer

Sublingual immunotherapy highly effective for chronic allergy and asthma sufferers

Countering neuroinflammation is indeed a potential therapeutic strategy for Alzheimer's

Krembil scientists develop lab study to accurately predict outcomes of stroke neuroprotectant

Ketamine can help improve brain function in Rett syndrome mice

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

Nature examines future of AMFm

Zimbabwe set to attain 'universal' ARV coverage

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News